PREDICTION OF RESPONSE TO PEGINTERFERON-ALFA-2B PLUS RIBAVIRIN THERAPY IN JAPANESE PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 1B

被引：0
|
作者：
Hashimoto, Yoshimasa [1 ,2 ]
Ochi, Hidenori [1 ,2 ]
Maekawa, Toshiro [2 ]
Abe, Hiromi [1 ,2 ]
Tsuge, Masataka [1 ,3 ]
Mitsui, Fukiko [1 ,3 ]
Hiraga, Nobuhiko [1 ,3 ]
Imamura, Michio [1 ,3 ]
Takahashi, Shoichi [1 ,3 ]
Hayes, C. Nelson [1 ,2 ]
Ohishi, Waka [3 ,4 ]
Chayama, Kazuaki [1 ,2 ]
机构：
[1] Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Hiroshima, Japan
[2] RIKEN Ctr Genom Med, Lab Liver Dis, Hiroshima, Japan
[3] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan
[4] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1872
引用
收藏
页码：1210A / 1210A
页数：1
相关论文
共 50 条
  • [1] Prediction of Response to Peginterferon-Alfa-2b Plus Ribavirin Therapy in Japanese Patients Infected With Hepatitis C Virus Genotype 1b
    Hashimoto, Yoshimasa
    Ochi, Hidenori
    Abe, Hiromi
    Hayashida, Yasufumi
    Tsuge, Masataka
    Mitsui, Fukiko
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Hayes, C. Nelson
    Ohishi, Waka
    Kubo, Michaki
    Tsunoda, Tatsuhiko
    Kamatani, Naoyuki
    Nakamura, Yusuke
    Chayama, Kazuaki
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (06) : 981 - 988
  • [2] Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
    Akuta, Norio
    Suzuki, Fumitaka
    Kawamura, SuzukiYusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1686 - 1695
  • [3] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Kanda, Tatsuo
    Imazeki, Fumio
    Azemoto, Ryosaku
    Yonemitsu, Yutaka
    Mikami, Shigeru
    Kita, Kazuhiko
    Takashi, Motohide
    Sunaga, Masahiko
    Wu, Shuang
    Nakamoto, Shingo
    Tawada, Akinobu
    Arai, Makoto
    Kato, Keizo
    Yoshida, Yu
    Koma, Yoshihiro
    Fujiwara, Keiichi
    Fukai, Kenichi
    Suzuki, Noriaki
    Yokosuka, Osamu
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (11) : 3335 - 3342
  • [4] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Tatsuo Kanda
    Fumio Imazeki
    Ryosaku Azemoto
    Yutaka Yonemitsu
    Shigeru Mikami
    Kazuhiko Kita
    Motohide Takashi
    Masahiko Sunaga
    Shuang Wu
    Shingo Nakamoto
    Akinobu Tawada
    Makoto Arai
    Keizo Kato
    Yu Yoshida
    Yoshihiro Koma
    Keiichi Fujiwara
    Kenichi Fukai
    Noriaki Suzuki
    Osamu Yokosuka
    [J]. Digestive Diseases and Sciences, 2011, 56 : 3335 - 3342
  • [5] Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nishino, Takayoshi
    Takada, Nobuo
    Tsubota, Akihito
    Kato, Keizo
    Miyamura, Tatsuo
    Maruoka, Daisuke
    Wu, Shuang
    Tanaka, Takeshi
    Arai, Makoto
    Mikami, Shigeru
    Fujiwara, Keiichi
    Imazeki, Fumio
    Yokosuka, Osamu
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (01): : 43 - 49
  • [6] Peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus
    Suzuki, Fumitaka
    Akuta, Norio
    Sezaki, Hitomi
    Yatsuji, Hiromi
    Arase, Yasuji
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Saitou, Satoshi
    Ikeda, Kenji
    Kumada, Hiromitsu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A115 - A115
  • [7] Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection genotype 4
    Shiha, Gamal
    Elshennaw, Hassan
    Abbas, Baha
    Khaled, Zalata
    Attia, Mohamed
    Farouk, Doaa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [8] Outcome in Partial Early Virologic Responders to Combination Therapy With Peginterferon and Ribavirin in Patients Infected With Hepatitis C Virus Genotype 1b
    Toyoda, Hidenori
    Kumada, Takashi
    Kiriyarna, Seiki
    Tanikawa, Makoto
    Hisanaga, Yasuhiro
    Kanamori, Akira
    Tada, Toshifumi
    Hosokawa, Takanori
    Arakawa, Takahiro
    Fujimori, Masashi
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (01) : 101 - 107
  • [9] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [10] Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1
    Izumi, Namiki
    Yokosuka, Osamu
    Kawada, Norifumi
    Osaki, Yukio
    Yamamoto, Kazuhide
    Sata, Michio
    Ishikawa, Hiroki
    Ueki, Tomoko
    Hu, Wenhua
    McPhee, Fiona
    Hughes, Eric A.
    Kumada, Hiromitsu
    [J]. ANTIVIRAL THERAPY, 2014, 19 (05) : 501 - 510
12345